Operating income increased 9.2%
Operating income changed +9.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +9.2% from the comparable as-filed period.
Inventory / revenue changed -195630 basis points from the comparable as-filed period.
SBC / revenue changed -16627 basis points from the comparable as-filed period.
Research & development changed -17.5% from the comparable as-filed period.
Trade receivables changed -16.2% from the comparable as-filed period.
Free-cash-flow margin changed +350443 basis points from the comparable as-filed period.
Operating cash-flow margin changed +334134 basis points from the comparable as-filed period.
R&D / revenue changed -284200 basis points from the comparable as-filed period.
Receivables / revenue changed -4962 basis points from the comparable as-filed period.
Stock-based compensation changed +7.1% from the comparable as-filed period.
Total assets changed -0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.